- Advertisement -

Seven Biopharma Trends to Watch in 2023

Industry predictions for 2023 based on a survey of 150-plus biopharma leaders were recently offered by PPD, Thermo Fisher Scientific’s clinical research business. The...

Black Death Selected for Immune-Related Genes, Affecting Disease Susceptibility Today

The Black Death was the single greatest mortality event in recorded history. Caused by the bacterium Yersinia pestis, the bubonic plague pandemic swept through North Africa,...

Exosomes from Heart Cells Can Be Therapeutic in Trauma Care

Nanoscale, secreted sacs called exosomes bud off from cellular membranes to fulfill diverse functions such as remodeling the tissue matrix and transmitting signals. Their...

Aston University scientists team up with Isterian Biotech to develop novel...

Aston University scientists are working with start-up company, Isterian Biotech, part of Cambrian BioPharma, to develop novel drugs to treat fibrotic diseases such as...

Study shows persistence of gender bias by patients in the health...

A new study has shown that patients are significantly more likely to correctly identify male physicians and female nurses, demonstrating continuing gender bias in...

Lixte Biotechnology and City of Hope Enroll First Patient in Phase...

Extensive preclinical data shows LB-100 increases the effectiveness of chemotherapy in animal modelsDue to the aggressive progression of small cell lung cancer, it is...

How Digital Orchestration Is Redefining Regulatory Infrastructure for Cell and Gene...

The rapid growth of cell and gene therapies is exposing structural limitations in how traditional biopharmaceutical systems were designed. Unlike batch-based manufacturing models, these...

ParcelBio Unveils Programmable mRNA Platform Backed by $13M Financing

Biotechnology company ParcelBio said this week that it has raised $13 million in a seed financing round led by Breyer Capital with participation from...

How Digital Orchestration Is Redefining Regulatory Infrastructure for Cell and Gene Therapy

The rapid growth of cell and gene therapies is exposing structural limitations in how traditional biopharmaceutical systems were designed. Unlike batch-based manufacturing models, these...

ParcelBio Unveils Programmable mRNA Platform Backed by $13M Financing

Biotechnology company ParcelBio said this week that it has raised $13 million in a seed financing round led by Breyer Capital with participation from...

New ‘heart-on-a-chip’ to halt cardiac damage caused by Duchenne

Duchenne Parent Project Spain (DPPE) has launched the BEAT Project, a research initiative focused on one of the key challenges associated with Duchenne and...

more new items

How Digital Orchestration Is Redefining Regulatory Infrastructure for Cell and Gene...

The rapid growth of cell and gene therapies is exposing structural limitations in how traditional biopharmaceutical systems were designed. Unlike batch-based manufacturing models, these...

ParcelBio Unveils Programmable mRNA Platform Backed by $13M Financing

Biotechnology company ParcelBio said this week that it has raised $13 million in a seed financing round led by Breyer Capital with participation from...

New ‘heart-on-a-chip’ to halt cardiac damage caused by Duchenne

Duchenne Parent Project Spain (DPPE) has launched the BEAT Project, a research initiative focused on one of the key challenges associated with Duchenne and...